Search - tctmd.com

Displaying 481 - 500 of 788

Sort: Relevancy | Date

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Designation as ‘Unfit for Open Repair’ Predicts Worse EVAR Outcomes

Leah Lawrence

September 13, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

September 04, 2013

News Conference News ESC 2013

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

Caitlin E. Cox

August 30, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

El Uso de Terapia Antianginosa Previa a una PCI en el Tratamiento de la EAC Estable Parece Bajo e Inconsistente

L.A. McKeown

August 23, 2013

News Daily News

Antianginal Therapy Use Before PCI in Stable CAD Appears Low, Inconsistent

L.A. McKeown

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Industry News

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

July 28, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

Advertisement

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Designation as ‘Unfit for Open Repair’ Predicts Worse EVAR Outcomes

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

FAME 2: La PCI Guiada por FFR resulta ‘Atractiva Económicamente’ comparada con Solo el Tratamiento Médico

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

El Uso de Terapia Antianginosa Previa a una PCI en el Tratamiento de la EAC Estable Parece Bajo e Inconsistente

Antianginal Therapy Use Before PCI in Stable CAD Appears Low, Inconsistent

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content